BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Perri F, Lorenzo GD, Scarpati GDV, Buonerba C. Anaplastic thyroid carcinoma: A comprehensive review of current and future therapeutic options. World J Clin Oncol 2011; 2(3): 150-157 [PMID: 21611089 DOI: 10.5306/wjco.v2.i3.150]
URL: https://www.wjgnet.com/2218-4333/full/v2/i3/150.htm
Number Citing Articles
1
Zubair W Baloch, Virginia A LiVolsi. Special types of thyroid carcinomaHistopathology 2018; 72(1): 40 doi: 10.1111/his.13348
2
Makoto Tahara, Naomi Kiyota, Tomoko Yamazaki, Naoko Chayahara, Kenji Nakano, Lina Inagaki, Kazuhisa Toda, Tomohiro Enokida, Hironobu Minami, Yoshinori Imamura, Tatsuya Sasaki, Takuya Suzuki, Katsuki Fujino, Corina E. Dutcus, Shunji Takahashi. Lenvatinib for Anaplastic Thyroid CancerFrontiers in Oncology 2017; 7 doi: 10.3389/fonc.2017.00025
3
Laurence Faugeras, Anne-Sophie Pirson, Julian Donckier, Luc Michel, Julien Lemaire, Sebastien Vandervorst, Lionel D’Hondt. Refractory thyroid carcinoma: which systemic treatment to use?Therapeutic Advances in Medical Oncology 2018; 10: 175883401775285 doi: 10.1177/1758834017752853
4
Matthias Lang, Thomas Longerich, Chrysanthi Anamaterou. Targeted therapy with vemurafenib in BRAF(V600E)-mutated anaplastic thyroid cancerThyroid Research 2023; 16(1) doi: 10.1186/s13044-023-00147-7
5
LORENZO ALLEGRI, FEDERICA BALDAN, CATIA MIO, CINZIA PUPPIN, DIEGO RUSSO, VLADIMIR KRYŠTOF, GIUSEPPE DAMANTE. Effects of BP-14, a novel cyclin-dependent kinase inhibitor, on anaplastic thyroid cancer cellsOncology Reports 2016; 35(4): 2413 doi: 10.3892/or.2016.4614
6
Enrique Grande, Juan José Díez, Carles Zafon, Jaume Capdevila. Thyroid Cancer: Molecular Aspects and New Therapeutic StrategiesJournal of Thyroid Research 2012; 2012: 1 doi: 10.1155/2012/847108
7
Kunal Ramesh Chandekar, Swayamjeet Satapathy, Chandrasekhar Bal. Positron Emission Tomography/Computed Tomography in Thyroid CancerPET Clinics 2024; 19(2): 131 doi: 10.1016/j.cpet.2023.12.001
8
Gheysen Laetitia, Saussez Sven, Journe Fabrice. Combinatorial Therapies in Thyroid Cancer: An Overview of Preclinical and Clinical ProgressesCells 2020; 9(4): 830 doi: 10.3390/cells9040830
9
Judy Jin, Roy Phitayakorn, Scott M. Wilhelm, Christopher R. McHenry. Advances in management of thyroid cancerCurrent Problems in Surgery 2013; 50(6): 241 doi: 10.1067/j.cpsurg.2013.02.001
10
A. L. Pylev, A. A. Zhandarova, K. S. Petrov, D. S. Romanov, V. A. Lisovoy, S. V. Golub. Anaplastic thyroid cancer. Is there a light at the end of the tunnel?Head and Neck Tumors (HNT) 2020; 10(1): 10 doi: 10.17650/2222-1468-2020-10-1-10-19
11
Gautham Chengizkhan, Bharti Bisht, Sridhar Muthusami, Muralidharan Anbalagan, Ilangovan Ramachandran, R. Ileng Kumaran. Cancer Stem Cells: New Horizons in Cancer Therapies2020; : 15 doi: 10.1007/978-981-15-5120-8_2
12
Esther Diana Rossi, William C. Faquin, Liron Pantanowitz. Aggressive Variants of Follicular- and Parafollicular-Derived Thyroid CarcinomaAJSP: Reviews and Reports 2019; 24(2): 61 doi: 10.1097/PCR.0000000000000297
13
Ling Ma, Qiao Cheng. Inhibiting 6-phosphogluconate dehydrogenase reverses doxorubicin resistance in anaplastic thyroid cancer via inhibiting NADPH-dependent metabolic reprogrammingBiochemical and Biophysical Research Communications 2018; 498(4): 912 doi: 10.1016/j.bbrc.2018.03.079
14
Petra Kühn. Palliative Viszeralchirurgie2019; : 275 doi: 10.1007/978-3-662-57362-4_22
15
Qingan Yu, Wenjing Jiang, Dan Li, Mingqi Gu, Kunpeng Liu, Liqian Dong, Chaoqun Wang, Hongchi Jiang, Wenjie Dai. Sodium orthovanadate inhibits growth and triggers apoptosis of human anaplastic thyroid carcinoma cells in vitro and in�vivoOncology Letters 2019;  doi: 10.3892/ol.2019.10090
16
CHENGHAI WANG, SIJIA LU, JIXIN JIANG, XIAOQIN JIA, XIAOYUN DONG, PING BU. Hsa-microRNA-101 suppresses migration and invasion by targeting Rac1 in thyroid cancer cellsOncology Letters 2014; 8(4): 1815 doi: 10.3892/ol.2014.2361
17
Robert I Haddad, Lindsay Bischoff, Douglas Ball, Victor Bernet, Erik Blomain, Naifa Lamki Busaidy, Michael Campbell, Paxton Dickson, Quan-Yang Duh, Hormoz Ehya, Whitney S. Goldner, Theresa Guo, Megan Haymart, Shelby Holt, Jason P. Hunt, Andrei Iagaru, Fouad Kandeel, Dominick M. Lamonica, Susan Mandel, Stephanie Markovina, Bryan McIver, Christopher D. Raeburn, Rod Rezaee, John A. Ridge, Mara Y. Roth, Randall P. Scheri, Jatin P. Shah, Jennifer A. Sipos, Rebecca Sippel, Cord Sturgeon, Thomas N. Wang, Lori J. Wirth, Richard J. Wong, Michael Yeh, Carly J. Cassara, Susan Darlow. Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in OncologyJournal of the National Comprehensive Cancer Network 2022; 20(8): 925 doi: 10.6004/jnccn.2022.0040
18
Yihui Lin, Jianjia Jiang. Long non-coding RNA LINC00704 promotes cell proliferation, migration, and invasion in papillary thyroid carcinoma via miR-204-5p/HMGB1 axisOpen Life Sciences 2020; 15(1): 561 doi: 10.1515/biol-2020-0057
19
Luisa Vicari, Cristina Colarossi, Dario Giuffrida, Ruggero De Maria, Lorenzo Memeo. Cancer stem cells as a potential therapeutic target in thyroid carcinomaOncology Letters 2016; 12(4): 2254 doi: 10.3892/ol.2016.4936
20
Oussama ElMokh, Dorothée Ruffieux-Daidié, Matthias A. Roelli, Amandine Stooss, Wayne A. Phillips, Jürg Gertsch, Matthias S. Dettmer, Roch-Philippe Charles. Combined MEK and Pi3′-kinase inhibition reveals synergy in targeting thyroid cancer in vitro and in vivoOncotarget 2017; 8(15): 24604 doi: 10.18632/oncotarget.15599
21
Christine Dierks, Dirk Vordermark, Kerstin Lorenz. Neuerungen in der Systemtherapie des Anaplastischen SchilddrüsenkarzinomsTumorDiagnostik & Therapie 2022; 43(06): 375 doi: 10.1055/a-1744-2100
22
Aurora Mirabile, Matteo Biafora, Leone Giordano, Gianluigi Arrigoni, Maria Giulia Cangi, Italo Dell’Oca, Francesca Lira Luce, Davide Di Santo, Andrea Galli, Michele Tulli, Renata Mellone, Davide Valsecchi, Vanesa Gregorc, Mario Bussi. Uncommon Site of Metastasis and Prolonged Survival in Patients with Anaplastic Thyroid Carcinoma: A Systematic Review of the LiteratureCancers 2020; 12(9): 2585 doi: 10.3390/cancers12092585
23
Zubair W. Baloch, Virginia A. LiVolsi. Thyroid Cancer2016; : 935 doi: 10.1007/978-1-4939-3314-3_96
24
Magdalena Rudzińska, Barbara Czarnocka. The Impact of Transcription Factor Prospero Homeobox 1 on the Regulation of Thyroid Cancer MalignancyInternational Journal of Molecular Sciences 2020; 21(9): 3220 doi: 10.3390/ijms21093220
25
Luca Hegedűs, Dominika Rittler, Tamás Garay, Paul Stockhammer, Ildikó Kovács, Balázs Döme, Sarah Theurer, Thomas Hager, Thomas Herold, Stavros Kalbourtzis, Agnes Bankfalvi, Kurt W. Schmid, Dagmar Führer, Clemens Aigner, Balázs Hegedűs. HDAC Inhibition Induces PD-L1 Expression in a Novel Anaplastic Thyroid Cancer Cell LinePathology & Oncology Research 2020; 26(4): 2523 doi: 10.1007/s12253-020-00834-y
26
Matthias A. Roelli, Dorothée Ruffieux-Daidié, Amandine Stooss, Oussama ElMokh, Wayne A. Phillips, Matthias S. Dettmer, Roch-Philippe Charles. PIK3CAH1047R-induced paradoxical ERK activation results in resistance to BRAFV600E specific inhibitors in BRAFV600E PIK3CAH1047R double mutant thyroid tumorsOncotarget 2017; 8(61): 103207 doi: 10.18632/oncotarget.21732
27
Denise Lovison, Lorenzo Allegri, Federica Baldan, Maurizio Ballico, Giuseppe Damante, Christian Jandl, Walter Baratta. Cationic carboxylate and thioacetate ruthenium(ii) complexes: synthesis and cytotoxic activity against anaplastic thyroid cancer cellsDalton Transactions 2020; 49(24): 8375 doi: 10.1039/D0DT01390K
28
Marilena Celano, Valentina Maggisano, Roberta Francesca De Rose, Stefania Bulotta, Jessica Maiuolo, Michele Navarra, Diego Russo. Flavonoid Fraction of Citrus Reticulata Juice Reduces Proliferation and Migration of Anaplastic Thyroid Carcinoma CellsNutrition and Cancer 2015; 67(7): 1183 doi: 10.1080/01635581.2015.1073760
29
Chuanzheng Sun, Chao Li, Zedong Hu, Xiaojiang Li, Jiehua He, Ming Song, Guojun Li, Fenghua Zhang, Qiuli Li. Influence of risk grouping on therapeutic decisions in patients with anaplastic thyroid carcinomaEuropean Archives of Oto-Rhino-Laryngology 2015; 272(4): 985 doi: 10.1007/s00405-014-2937-2
30
Zubair Baloch, Virginia A LiVolsi, Rashmi Tondon. Aggressive variants of follicular cell derived thyroid carcinoma; the so called ‘Real Thyroid Carcinomas’Journal of Clinical Pathology 2013; 66(9): 733 doi: 10.1136/jclinpath-2013-201626
31
Eun Mee Oh, Kyu Eun Lee, Hyungju Kwon, Eun Young Kim, Dong Sik Bae, Yeo-Kyu Youn. Analysis of patients with anaplastic thyroid cancer expected to have curative surgeryJournal of the Korean Surgical Society 2012; 83(3): 123 doi: 10.4174/jkss.2012.83.3.123
32
Gennaro Di Maro, Francesca Maria Orlandella, Tammaro Claudio Bencivenga, Paolo Salerno, Clara Ugolini, Fulvio Basolo, Roberta Maestro, Giuliana Salvatore. Identification of Targets of Twist1 Transcription Factor in Thyroid Cancer CellsThe Journal of Clinical Endocrinology & Metabolism 2014; 99(9): E1617 doi: 10.1210/jc.2013-3799
33
Ulrike Hinterseher, Annette Wunderlich, Silvia Roth, Annette Ramaswamy, Detlef K. Bartsch, Stefan Hauptmann, Brandon H. Greene, Volker Fendrich, Sebastian Hoffmann. Expression of hedgehog signalling pathway in anaplastic thyroid cancerEndocrine 2014; 45(3): 439 doi: 10.1007/s12020-013-0015-y
34
Francesco Perri, Antonio Giordano, Salvatore Pisconti, Franco Ionna, Maria G. Chiofalo, Francesco Longo, Davide Leopardo, Giuseppina Della Vittoria Scarpati, Luciano Pezzullo. Thyroid cancer managementAnti-Cancer Drugs 2018; 29(6): 483 doi: 10.1097/CAD.0000000000000617
35
Xiawei Shen, Yali Zhu, Zuixuan Xiao, Xuemei Dai, Dan Liu, Lin Li, Baolai Xiao. Antiviral Drug Ribavirin Targets Thyroid Cancer Cells by Inhibiting the eIF4E-β-Catenin AxisThe American Journal of the Medical Sciences 2017; 354(2): 182 doi: 10.1016/j.amjms.2017.03.025
36
Alessio Terenzi, Laura Tomasello, Angelo Spinello, Giuseppe Bruno, Carla Giordano, Giampaolo Barone. (Dipyrido[3,2-a:2′,3′-c]phenazine)(glycinato)copper(II) perchlorate: A novel DNA-intercalator with anti-proliferative activity against thyroid cancer cell linesJournal of Inorganic Biochemistry 2012; 117: 103 doi: 10.1016/j.jinorgbio.2012.08.011
37
Lisa M. Greene, Niamh M. O’Boyle, Derek P. Nolan, Mary J. Meegan, Daniela M. Zisterer. The vascular targeting agent Combretastatin-A4 directly induces autophagy in adenocarcinoma-derived colon cancer cellsBiochemical Pharmacology 2012; 84(5): 612 doi: 10.1016/j.bcp.2012.06.005
38
Natalie M. Lowe, Sean Loughran, Nicholas J. Slevin, Beng K. Yap. Anaplastic Thyroid Cancer: The Addition of Systemic Chemotherapy to Radiotherapy Led to an Observed Improvement in Survival—A Single Centre Experience and Review of the LiteratureThe Scientific World Journal 2014; 2014: 1 doi: 10.1155/2014/674583
39
Christine Dierks. Systemtherapie des anaplastischen SchilddrüsenkarzinomsDie Onkologie 2022; 28(8): 642 doi: 10.1007/s00761-022-01198-5
40
John C. Deutsch. Gastrointestinal Endoscopy in the Cancer Patient2013; : 327 doi: 10.1002/9781118555651.ch31
41
Christina A von Roemeling, John A Copland. Targeting lipid metabolism for the treatment of anaplastic thyroid carcinomaExpert Opinion on Therapeutic Targets 2016; 20(2): 159 doi: 10.1517/14728222.2016.1086341
42
Suresh Chandra Sharma, Pirabu Sakthivel, Sarath Raveendran, Chirom Amit Singh, Tripti Nakra, Shipra Agarwal. Anaplastic Carcinoma Thyroid in a Young Child – an Extremely Rare OccurrenceActa Medica (Hradec Kralove, Czech Republic) 2018; 61(4): 150 doi: 10.14712/18059694.2018.134
43
Valeria G. Antico Arciuch, Marika A. Russo, Mariavittoria Dima, Kristy S. Kang, Florence Dasrath, Xiao-Hui Liao, Samuel Refetoff, Cristina Montagna, Antonio Di Cristofano. Thyrocyte-specific inactivation of p53 and Pten results in anaplastic thyroid carcinomas faithfully recapitulating human tumorsOncotarget 2011; 2(12): 1109 doi: 10.18632/oncotarget.380
44
Ling Ma, Honghua Fei. Antimalarial drug artesunate is effective against chemoresistant anaplastic thyroid carcinoma via targeting mitochondrial metabolismJournal of Bioenergetics and Biomembranes 2020; 52(2): 123 doi: 10.1007/s10863-020-09824-w
45
S. Lopes-Ventura, M. Pojo, A. T. Matias, M. M. Moura, I. J. Marques, V. Leite, B. M. Cavaco. The efficacy of HRAS and CDK4/6 inhibitors in anaplastic thyroid cancer cell linesJournal of Endocrinological Investigation 2019; 42(5): 527 doi: 10.1007/s40618-018-0947-4
46
Ricardo R. Lastra, Virginia A. LiVolsi, Zubair W. Baloch. Aggressive variants of follicular cell‐derived thyroid carcinomas: A cytopathologist's perspectiveCancer Cytopathology 2014; 122(7): 484 doi: 10.1002/cncy.21417
47
Elisa Stellaria Grassi, Viola Ghiandai, Luca Persani. Thyroid Cancer Stem-Like Cells: From Microenvironmental Niches to Therapeutic StrategiesJournal of Clinical Medicine 2021; 10(7): 1455 doi: 10.3390/jcm10071455
48
Jing Liu, Liguo Feng, Haitao Zhang, Jin Zhang, Yanyan Zhang, Shujing Li, Long Qin, Ziyao Yang, Jianxia Xiong. Effects of miR-144 on the sensitivity of human anaplastic thyroid carcinoma cells to cisplatin by autophagy regulationCancer Biology & Therapy 2018; 19(6): 484 doi: 10.1080/15384047.2018.1433502
49
Ying Wang, Zhigang Hu, Weiyuan Ma, Yong Niu, Jingwei Su, Lingxiang Zhang, Pengxin Zhao. Signal transducer and activator of transcription 3 inhibition alleviates resistance to BRAF inhibition in anaplastic thyroid cancerInvestigational New Drugs 2021; 39(3): 764 doi: 10.1007/s10637-020-01024-y
50
Emi Date, Kunio Okamoto, Souichi Fumita, Hiroyasu Kaneda. Gastrointestinal perforation related to lenvatinib, an anti-angiogenic inhibitor that targets multiple receptor tyrosine kinases, in a patient with metastatic thyroid cancerInvestigational New Drugs 2018; 36(2): 350 doi: 10.1007/s10637-017-0522-4
51
Enrico Maria Amadei, Laura Benedettini, Ottavio Piccin. Two Cases of Cervical Hemorrhage with Upper Airway Obstruction: A Life-Threatening ConditionCase Reports in Medicine 2014; 2014: 1 doi: 10.1155/2014/674176
52
Yi-Tian Li, Xiao-Ting Tian, Mo-Li Wu, Xu Zheng, Qing-You Kong, Xiao-Xin Cheng, Guang-Wen Zhu, Jia Liu, Hong Li. Resveratrol Suppresses the Growth and Enhances Retinoic Acid Sensitivity of Anaplastic Thyroid Cancer CellsInternational Journal of Molecular Sciences 2018; 19(4): 1030 doi: 10.3390/ijms19041030
53
Hilda Samimi, Rezvan Tavakoli, Parviz Fallah, Alireza Naderi Sohi, Maryam Amini Shirkouhi, Mahmood Naderi, Vahid Haghpanah. BI-847325, a selective dual MEK and Aurora kinases inhibitor, reduces aggressive behavior of anaplastic thyroid carcinoma on an in vitro three-dimensional cultureCancer Cell International 2022; 22(1) doi: 10.1186/s12935-022-02813-6
54
Kun Hu, Juan Zhang, Min Yu, Chang’e Xiong. Inhibition of Mnk–eIF4E Pathway Sensitizes The Efficacy to Chemotherapy in Anaplastic Thyroid CancerFuture Oncology 2017; 13(6): 489 doi: 10.2217/fon-2016-0320
55
Haoran Feng, Xi Cheng, Jie Kuang, Lingxie Chen, Stanley Yuen, Minmin Shi, Juyong Liang, Baiyong Shen, Zhijian Jin, Jiqi Yan, Weihua Qiu. Apatinib-induced protective autophagy and apoptosis through the AKT–mTOR pathway in anaplastic thyroid cancerCell Death & Disease 2018; 9(10) doi: 10.1038/s41419-018-1054-3
56
Julie Bolin. Thyroid Follicular Epithelial Cell–Derived Cancer: New Approaches and Treatment StrategiesJournal of Nuclear Medicine Technology 2021; 49(3): 199 doi: 10.2967/jnmt.120.257105
57
Manoj Garg, Deepika Kanojia, Anand Mayakonda, Trivadi S Ganesan, Bindhya Sadhanandhan, Sidhanth Suresh, Sneha S., Rohit P. Nagare, Jonathan W. Said, Ngan B. Doan, Ling-Wen Ding, Erkan Baloglu, Sharon Shacham, Michael Kauffman, H. Phillip Koeffler. Selinexor (KPT-330) has antitumor activity against anaplastic thyroid carcinoma in vitro and in vivo and enhances sensitivity to doxorubicinScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-10325-x
58
Dongbin Ahn, Jin Ho Sohn. Anaplastic Thyroid Carcinoma: Experience of a Single InstituteKorean Journal of Otorhinolaryngology-Head and Neck Surgery 2012; 55(1): 37 doi: 10.3342/kjorl-hns.2012.55.1.37
59
Anne-Katrin Dumke, Tanja Pelz, Dirk Vordermark. Long-term results of radiotherapy in anaplastic thyroid cancerRadiation Oncology 2014; 9(1) doi: 10.1186/1748-717X-9-90
60
Xiayun He, Duanshu Li, Chaosu Hu, Zhuoying Wang, Hongmei Ying, Yi Wu. Outcome after intensity modulated radiotherapy for anaplastic thyroid carcinomaBMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-235
61
Vincenzo Marotta, Maria Domenica Franzese, Michela Del Prete, Maria Grazia Chiofalo, Valeria Ramundo, Raffaella Esposito, Francesca Marciello, Luciano Pezzullo, Annachiara Carratù, Mario Vitale, Annamaria Colao, Antongiulio Faggiano. Targeted therapy with kinase inhibitors in aggressive endocrine tumorsExpert Opinion on Pharmacotherapy 2013; 14(9): 1187 doi: 10.1517/14656566.2013.796931
62
Fundamentals of Cancer Detection, Treatment, and Prevention2022; : 395 doi: 10.1002/9783527838561.ch18
63
Haralabos Koussis, Carlo Alberto Giorgi, Elisabetta Di Liso, Maria Concetta Carlucci, Ambrogio Fassina, Gino Marioni, Pier Franco Conte. Complete response to weekly carboplatin–docetaxel chemotherapy in a 91-year-old woman with anaplastic thyroid cancerAmerican Journal of Otolaryngology 2015; 36(2): 268 doi: 10.1016/j.amjoto.2014.03.006
64
Mathias Montenarh, Nathaniel E. B. Saidu. The Effect of Diallyl Polysulfanes on Cellular Signaling CascadesNatural Product Communications 2012; 7(3): 1934578X1200700 doi: 10.1177/1934578X1200700324
65
Catia Mio, Elisa Lavarone, Ketty Conzatti, Federica Baldan, Barbara Toffoletto, Cinzia Puppin, Sebastiano Filetti, Cosimo Durante, Diego Russo, Arturo Orlacchio, Antonio Di Cristofano, Carla Di Loreto, Giuseppe Damante. MCM5 as a target of BET inhibitors in thyroid cancer cellsEndocrine-Related Cancer 2016; 23(4): 335 doi: 10.1530/ERC-15-0322